Aurora Hires Former GeneProt Exec as VP, Business Development | GenomeWeb

NEW YORK, March 23 – Aurora Biosciences said it has hired William Ettouati, former co-CEO of Geneva Proteomics, as vice president of business development.

Ettouati, who was at the helm of Geneva Proteomics from April to August of last year, will seek to expand Aurora’s business in Europe and develop other strategic alliances, Aurora said. Before his term at GeneProt, Ettouati headed up Ceptyr, a Seattle-based biotech company developing PTP-based therapeutics. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.